The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

NIH Conflict-Of-Interest Regs Impending

The Scientist Placeholder Image

More Biotech Ph.D.'s Opting To Take Postdocs In Industry

The Scientist Placeholder Image

Undergraduate Enrollment Drop Threatens Nuclear Science

The Scientist Placeholder Image

Lasker Officials Vow To Carry On In Tradition Established By Alice Fordyce

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Renewed SSC Funding Fails To Eliminate Physicists' Concerns

The Scientist Placeholder Image

Undaunted By Death Of First Baboon Liver Recipient, Interdisciplinary Transplant Team Looks To The Future

The Scientist Placeholder Image

Academy Criticism Of A Foreign Associate Stirs Debate Over NAS Role And Policies

The Scientist Placeholder Image

Seven To Receive 1992 Gairdner Awards

The Scientist Placeholder Image

NSB Panel To Help NSF Plan Its Post-Cold War Future

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

Observers See Healy Tenure At NIH Helm In Jeopardy If Clinton Is Elected President

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies